Ogata, R., Kishino, E., Saitoh, W., Koike, Y., & Kurebayashi, J. (2020). Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells. Breast Cancer.
Citação norma ChicagoOgata, Ryohei, Emi Kishino, Wataru Saitoh, Yoshikazu Koike, and Junichi Kurebayashi. "Resistance to Cyclin-dependent Kinase (CDK) 4/6 Inhibitors Confers Cross-resistance to Other CDK Inhibitors but Not to Chemotherapeutic Agents in Breast Cancer Cells." Breast Cancer 2020.
Citação norma MLAOgata, Ryohei, et al. "Resistance to Cyclin-dependent Kinase (CDK) 4/6 Inhibitors Confers Cross-resistance to Other CDK Inhibitors but Not to Chemotherapeutic Agents in Breast Cancer Cells." Breast Cancer 2020.